A team from The University of Texas at Austin (TX, USA) are developing a sensor capable of testing for COVID-19 and influenza simultaneously.
Researchers have developed a thread-based bioluminescence sensor capable of detecting antibodies in a finger prick sample of whole blood.
BioAgilytix (NC, USA), a Durham-based CRO, have announced the launch of customizable testing packages to address the requirements of employees and sponsors as a result of the COVID-19 pandemic.
Avacta (Cambridge, UK) has announced that the bead-assisted mass spectrometry test for COVID-19, currently in development with Adeptrix (MA, USA), has reached prototype stage.
Read expert answers to audience submitted questions during the recent panel discussion – COVID-19 and patient-centric sampling: how to fight a pandemic.
Thermo Fisher Scientific (MA, USA), WuXi Diagnostics (Shanghai, China) and Mayo Clinic (MN, USA) are collaborating to develop and validate a serology test for COVID-19.
Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA
The US FDA has expanded the emergency use authorization granted to Thermo Fisher Scientific’s (MA, USA) COVID-19 diagnostic test. The expansion could facilitate workflow flexibility and increase test throughput.
Researchers have developed a tool that could help to monitor the spread of infectious diseases. The newly developed blood test could provide information about whether and when an individual has been exposed to infection.
Mologic (Bedford, UK) and BioSure (Essex, UK) have entered a partnership to produce an antibody self-test for COVID-19 that does not require specialist equipment or training to carry out.
A study led by researchers from Brussels Academic Hospital Lab (LHUB-ULB, Brussels, Belgium) indicates that the COVID-19 Ag Respi-Strip® – an antigen test for COVID-19 – could be a useful component in broader testing strategies.